Aptevo

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptevo and other ETFs, options, and stocks.

About APVO

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. 

CEO
Marvin L. White
CEOMarvin L. White
Employees
42
Employees42
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
2016
Founded2016
Employees
42
Employees42

APVO Key Statistics

Market cap
2.16M
Market cap2.16M
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
6.19M
Average volume6.19M
High today
$0.6916
High today$0.6916
Low today
$0.622
Low today$0.622
Open price
$0.66
Open price$0.66
Volume
415.44K
Volume415.44K
52 Week high
$51.06
52 Week high$51.06
52 Week low
$0.6036
52 Week low$0.6036
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.